GHRH + GHRP Blend
CJC-1295 + Ipamorelin
GH Secretagogue Blend
This is a research blend of two peptides, CJC-1295 and Ipamorelin, studied for how they signal the body to release its own growth hormone. CJC-1295 is researched for extending the signal so it lasts longer, while Ipamorelin is studied for triggering a targeted release. The pairing is widely researched because the two parts are thought to support each other, with little effect on other hormones like cortisol.
Select size
Buy more, save more
Applied automatically by total quantity in your cart. Stacks with the 10% crypto discount.
Free US shipping. Ships from our US warehouse in 5-7 days - order today, arrives Jun 28 - Jun 30.
Best price online. Compare it anywhere - this is the lowest you will find.
Third-party tested. COA available for this batch (≥99.2% purity).
Crypto checkout. Pay with BTC, ETH, or USDC and save 10%.
Add bacteriostatic water to your order
Required to reconstitute peptides - not included.
Overview
CJC-1295 Ipamorelin is a research grade peptide blend pairing two synthetic compounds that appear together throughout the growth-hormone secretagogue literature. In published studies, CJC-1295 is described as a long-acting analog of growth-hormone-releasing hormone (GHRH), a modified hGRF(1-29) sequence, while Ipamorelin is a pentapeptide characterized as an agonist at the GH secretagogue (ghrelin) receptor. The two are studied as a combination because they engage separate receptor systems on pituitary somatotrophs in preclinical models.
Researchers reference this cjc-1295 ipamorelin blend as a tool for probing the somatotropic axis. In rat models, CJC-1295 was characterized as an albumin-binding GRF analog with extended plasma presence (Jette et al., 2005), while Ipamorelin was reported in its 1998 characterization to release growth hormone with potency comparable to GHRP-6 yet without the significant cortisol or ACTH elevation seen with other secretagogues (Raun et al., 1998). All observations are confined to animal and in-vitro systems and reflect no human or therapeutic effect.
VANTA supplies this cjc-1295 ipamorelin peptide as a reference standard for qualified laboratory investigators. Each lot is verified for identity by mass spectrometry against the theoretical mass for both peptide sequences and assessed for purity by reversed-phase HPLC, which resolves the target peptides from process-related impurities. Material ships as a lyophilized powder with a per-batch Certificate of Analysis. Everything offered here is strictly for laboratory research use only and is not for human or animal administration.
Research Areas
Handling & Reconstitution
This blend ships as a lyophilized powder and should be stored at -20°C until reconstitution. For research handling, the lyophilized powder is typically reconstituted with bacteriostatic or sterile water within a laboratory setting, after which it is kept refrigerated at 2-8°C. Reported half-lives in the literature differ between the components: CJC-1295 around 30 minutes and Ipamorelin around 2 hours. Protect from light, avoid repeated freeze-thaw cycles, and follow institutional protocols.
Frequently asked questions
What is CJC-1295 Ipamorelin?
It is a research blend of two synthetic peptides studied together in the growth-hormone secretagogue literature. CJC-1295 is described as a long-acting GHRH analog and Ipamorelin as a ghrelin-receptor agonist. They engage separate receptor systems on pituitary somatotrophs and are examined in preclinical and in-vitro models only.
What form and purity is this CJC-1295 Ipamorelin peptide supplied in?
VANTA supplies the blend as a lyophilized powder. Purity is assessed by reversed-phase HPLC, which resolves the target peptides from process-related impurities and quantifies the main-peak percentage, while identity is confirmed by mass spectrometry against the theoretical mass for each sequence in the combination.
How should research grade CJC-1295 Ipamorelin be stored and reconstituted?
Store the lyophilized powder at -20°C. After reconstitution in a laboratory setting, keep it refrigerated at 2-8°C, protect it from light, and avoid repeated freeze-thaw cycles. Follow your institution's standard protocols for handling research peptides to support stability and reproducibility.
Is this CJC-1295 Ipamorelin blend third-party tested with a COA?
Yes. Every VANTA lot is verified before shipping and includes a per-batch Certificate of Analysis documenting the HPLC purity result, mass-spec identity confirmation, and lot-specific details. This independent analytical record lets a laboratory confirm what was received and supports traceability in research-use-only workflows.
What research areas is CJC-1295 Ipamorelin studied in?
In the published literature these peptides are referenced in studies of GHRH-receptor and ghrelin-receptor signaling and their convergence on pituitary GH regulation. Researchers have used such compounds as pharmacological probes for GH pulsatility in animal and cell-culture systems. Findings are limited to laboratory models, not human outcomes.
Is CJC-1295 Ipamorelin intended for human use?
No. This blend is supplied strictly for laboratory research use only. It is not a drug, supplement, or medical product, and it is not intended for human or animal consumption, administration, or any diagnostic or therapeutic application. Handling is restricted to qualified research professionals.
Specifications
- Research Class
- GHRH + GHRP Blend
- Half-Life
- CJC-1295 ~30 min; Ipamorelin ~2 hours
- Form
- Lyophilized Powder
- Storage
- Lyophilized: -20°C. Reconstituted: 2-8°C.
For laboratory research use only. Not for human consumption, diagnostic, or therapeutic use. Must be 21+ to purchase.
More in Growth & Performance
CJC-1295 (No DAC)
A short-acting peptide researched for the body's natural growth hormone bursts.
Ipamorelin
A selective peptide researched for prompting natural growth hormone release in clean pulses.
Tesamorelin
A long-lasting peptide researched for growth hormone release and deep belly fat.